MTLS (MTLS) revenue breakdown
By segment, Materialise Medical is the largest at 50% of fiscal 2025 revenue, growing 14% a year over 6 years.
By product, Medical devices and services is the largest at 36% of fiscal 2025 revenue, growing 19% a year over 3 years.
Revenue by segment
Fiscal years, as MTLS reports them in its 10-K filings; fiscal 2025 total $268M.
| Segments | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| Materialise Medical | $61M | $62M | $73M | $85M | $101M | $116M | $134M | 50% |
| Materialise Manufacturing | $94M | $70M | $89M | $103M | $110M | $107M | $92M | 35% |
| Materialise Software | $42M | $39M | $43M | $44M | $44M | $44M | $41M | 15% |
| Unallocated | $61,000 | — | — | — | — | — | — | — |
| Unallocated | — | $31,000 | — | — | — | — | — | — |
Revenue by product
Fiscal years, as MTLS reports them in its 10-K filings; fiscal 2025 total $268M.
| Products | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|
| Medical devices and services | $58M | $70M | $83M | $97M | 36% |
| Manufacturing | $103M | $110M | $107M | $92M | 35% |
| Software (non-medical) | $44M | $44M | $44M | $41M | 15% |
| Software revenue (medical) | $27M | $32M | $34M | $37M | 14% |
Revenue by region
Fiscal years, as MTLS reports them in its 10-K filings; fiscal 2025 total $268M.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| United States of America | $33M | $42M | $56M | $47M | $69M | $79M | $90M | $109M | $111M | 41% |
| Germany | $27M | $30M | $31M | $17M | $20M | $30M | $33M | $35M | $31M | 12% |
| Other Europe | $3M | $21M | $17M | $32M | $34M | $29M | $23M | $23M | $26M | 10% |
| Switzerland | $8M | $13M | $15M | $13M | $14M | $17M | $21M | $20M | $20M | 8% |
| Asia-Pacific | $20M | $20M | $19M | $18M | $20M | $20M | $20M | $18M | $19M | 7% |
| France | $19M | $22M | $20M | $12M | $13M | $16M | $19M | $17M | $17M | 6% |
| United Kingdom | $11M | $12M | $14M | $8M | $9M | $11M | $15M | $16M | $15M | 6% |
| Italy | $4M | $4M | $7M | $6M | $7M | $8M | $11M | $8M | $8M | 3% |
| Netherlands | $8M | $7M | $6M | $7M | $7M | $7M | $8M | $8M | $7M | 3% |
| Americas other than USA | $2M | $2M | $3M | $5M | $6M | $8M | $7M | $7M | $6M | 2% |
| Belgium | $8M | $9M | $8M | $7M | $7M | $7M | $8M | $7M | $6M | 2% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for MTLS.
Open MTLS in InvestinglyQuestions
Where does MTLS make its money?
In fiscal 2025, by segment: Materialise Medical $134M, Materialise Manufacturing $92M, Materialise Software $41M.
From MTLS's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.